Compare Revvity Inc (RVTY) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance

RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.

The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.

TLH trades at $98.13, down 0.56% over 24 hours, with technical indicators signaling a bearish trend. The stock faces resistance near $99 and support at $97. Recent dividend payments of $0.41 and $0.36 in mid-2026 provide income, but key financial ratios like P/E and ROE are unavailable, limiting fundamental clarity. Broader market volatility, driven by Federal Reserve uncertainty and geopolitical tensions, adds to the cautious backdrop.

The outlook for TLH remains guarded due to weak technical momentum and lack of visible fundamental strength. Investment opportunity hinges on improved earnings visibility and stabilization above key support. Risks include macroeconomic pressures and absence of current financial metrics, warranting careful monitoring for signs of operational improvement or further deterioration.